OSL ASX · Health Care

Oncosil Medical Ltd

Announcements, last 12 months: 114
Price sensitive, last 12 months: 25
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
21 Oct 2026, 9:10 AM	Updated OSPREY Overall Survival Data Presented at EAMN
19 Oct 2026, 10:01 AM	Notice of Annual General Meeting/Proxy Form
15 Oct 2026, 3:34 PM	Application for quotation of securities - OSL
13 Oct 2026, 9:59 AM	PALACROS Officially Launched in Amsterdam
30 Sep 2026, 9:27 AM	OncoSil Clinical Data to be Presented at EANM 2026
28 Sep 2026, 1:26 PM	Notice of AGM date
15 Sep 2026, 9:04 AM	Notice under ASX Listing Rule 3.10A
14 Sep 2026, 4:52 PM	Change in substantial holding
14 Sep 2026, 8:39 AM	Change in substantial shareholding from AEF
10 Sep 2026, 11:21 AM	Notice Under Section 708A

Sign in to see all OSL announcements.

Guidance history

9 Sep 2026	Target to commence production by end of 2Q FY27
17 Aug 2026	Annual U.S. addressable market of approximately A$80 million per annum

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow OSL to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.